Jonathan Walklate

509 total citations
16 papers, 321 citations indexed

About

Jonathan Walklate is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Genetics. According to data from OpenAlex, Jonathan Walklate has authored 16 papers receiving a total of 321 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Cardiology and Cardiovascular Medicine, 14 papers in Molecular Biology and 2 papers in Genetics. Recurrent topics in Jonathan Walklate's work include Cardiomyopathy and Myosin Studies (15 papers), Muscle Physiology and Disorders (9 papers) and Cardiovascular Effects of Exercise (9 papers). Jonathan Walklate is often cited by papers focused on Cardiomyopathy and Myosin Studies (15 papers), Muscle Physiology and Disorders (9 papers) and Cardiovascular Effects of Exercise (9 papers). Jonathan Walklate collaborates with scholars based in United Kingdom, United States and Serbia. Jonathan Walklate's co-authors include Michael A. Geeves, Zoltán Ujfalusi, Michael Regnier, Leslie A. Leinwand, Carlos Vera, Corrado Poggesi, Chiara Tesi, Marieke J. Bloemink, Boban Stojanović and Cecilia Ferrantini and has published in prestigious journals such as Journal of Biological Chemistry, Analytical Biochemistry and Biophysical Journal.

In The Last Decade

Jonathan Walklate

16 papers receiving 319 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jonathan Walklate United Kingdom 11 268 182 30 28 20 16 321
Irene Pertici Italy 12 174 0.6× 158 0.9× 53 1.8× 41 1.5× 48 2.4× 24 287
Daniil V. Shchepkin Russia 12 364 1.4× 241 1.3× 56 1.9× 32 1.1× 17 0.8× 55 426
Sengen Xu United States 8 177 0.7× 153 0.8× 53 1.8× 47 1.7× 30 1.5× 11 330
Galina V. Kopylova Russia 13 375 1.4× 246 1.4× 59 2.0× 37 1.3× 22 1.1× 58 448
Alexander M. Matyushenko Russia 12 350 1.3× 262 1.4× 68 2.3× 39 1.4× 10 0.5× 48 414
Petr G. Vikhorev United Kingdom 11 271 1.0× 187 1.0× 55 1.8× 33 1.2× 20 1.0× 15 358
John A. Rohde United States 7 275 1.0× 176 1.0× 38 1.3× 38 1.4× 14 0.7× 9 314
Henry Gong United States 12 575 2.1× 293 1.6× 27 0.9× 41 1.5× 46 2.3× 24 619
Makenna M. Morck United States 5 369 1.4× 257 1.4× 15 0.5× 15 0.5× 19 0.9× 5 477
Amanda C. Garfinkel United States 6 304 1.1× 176 1.0× 28 0.9× 7 0.3× 23 1.1× 11 380

Countries citing papers authored by Jonathan Walklate

Since Specialization
Citations

This map shows the geographic impact of Jonathan Walklate's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonathan Walklate with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonathan Walklate more than expected).

Fields of papers citing papers by Jonathan Walklate

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonathan Walklate. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonathan Walklate. The network helps show where Jonathan Walklate may publish in the future.

Co-authorship network of co-authors of Jonathan Walklate

This figure shows the co-authorship network connecting the top 25 collaborators of Jonathan Walklate. A scholar is included among the top collaborators of Jonathan Walklate based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonathan Walklate. Jonathan Walklate is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Walklate, Jonathan, et al.. (2023). Distinct effects of two hearing loss–associated mutations in the sarcomeric myosin MYH7b. Journal of Biological Chemistry. 299(5). 104631–104631. 2 indexed citations
2.
Walklate, Jonathan, et al.. (2022). Single-molecule imaging reveals how mavacamten and PKA modulate ATP turnover in skeletal muscle myofibrils. The Journal of General Physiology. 155(1). 14 indexed citations
3.
Meller, Artur, Jonathan Walklate, Jeffrey M. Lotthammer, et al.. (2022). Functional divergence of the sarcomeric myosin, MYH7b, supports species-specific biological roles. Journal of Biological Chemistry. 299(1). 102657–102657. 11 indexed citations
4.
Walklate, Jonathan, et al.. (2022). Exploring the super-relaxed state of myosin in myofibrils from fast-twitch, slow-twitch, and cardiac muscle. Journal of Biological Chemistry. 298(3). 101640–101640. 33 indexed citations
5.
Kopylova, Galina V., Daniil V. Shchepkin, Jonathan Walklate, et al.. (2022). Pseudo-phosphorylation of essential light chains affects the functioning of skeletal muscle myosin. Biophysical Chemistry. 292. 106936–106936. 1 indexed citations
6.
Walklate, Jonathan, et al.. (2021). Alpha and beta myosin isoforms and human atrial and ventricular contraction. Cellular and Molecular Life Sciences. 78(23). 7309–7337. 34 indexed citations
7.
McGreig, Jake E, Jonathan Walklate, Carlos Vera, et al.. (2021). Identification of sequence changes in myosin II that adjust muscle contraction velocity. PLoS Biology. 19(6). e3001248–e3001248. 10 indexed citations
8.
Pavadai, Elumalai, Michael J. Rynkiewicz, Jonathan Walklate, et al.. (2020). Cryo-EM and Molecular Docking Shows Myosin Loop 4 Contacts Actin and Tropomyosin on Thin Filaments. Biophysical Journal. 119(4). 821–830. 41 indexed citations
9.
Walklate, Jonathan, et al.. (2019). A micro-volume adaptation of a stopped-flow system; use with μg quantities of muscle proteins. Analytical Biochemistry. 581. 113338–113338. 3 indexed citations
10.
Vera, Carlos, Jonathan Walklate, Arjun S. Adhikari, et al.. (2019). Myosin motor domains carrying mutations implicated in early or late onset hypertrophic cardiomyopathy have similar properties. Journal of Biological Chemistry. 294(46). 17451–17462. 27 indexed citations
11.
Walklate, Jonathan, et al.. (2019). The ATPase cycle of human muscle myosin II isoforms: Adaptation of a single mechanochemical cycle for different physiological roles. Journal of Biological Chemistry. 294(39). 14267–14278. 16 indexed citations
12.
Stojanović, Boban, et al.. (2017). Modeling the Actin.myosin ATPase Cross-Bridge Cycle for Skeletal and Cardiac Muscle Myosin Isoforms. Biophysical Journal. 112(5). 984–996. 44 indexed citations
13.
Walklate, Jonathan, Carlos Vera, Marieke J. Bloemink, Michael A. Geeves, & Leslie A. Leinwand. (2016). The Most Prevalent Freeman-Sheldon Syndrome Mutations in the Embryonic Myosin Motor Share Functional Defects. Journal of Biological Chemistry. 291(19). 10318–10331. 28 indexed citations
14.
Walklate, Jonathan, Zoltán Ujfalusi, & Michael A. Geeves. (2016). Myosin isoforms and the mechanochemical cross-bridge cycle. Journal of Experimental Biology. 219(2). 168–174. 46 indexed citations
15.
Walklate, Jonathan & Michael A. Geeves. (2015). Temperature manifold for a stopped-flow machine to allow measurements from −10 to +40 °C. Analytical Biochemistry. 476. 11–16. 10 indexed citations
16.
Walklate, Jonathan, et al.. (2015). Functional Analysis of Freeman-Sheldon Syndrome Causing Mutations on Embryonic Myosin. Biophysical Journal. 108(2). 304a–304a. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026